Synthetic Biologics shares owned by UBS Group
Quarter-by-quarter ownership of Synthetic Biologics (TOVX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Synthetic Biologics
Tip: Access up to 7 years of quarterly data
All positions including Synthetic Biologics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Synthetic Biologics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $0 | 3 | 0.33 |
| 2023-12-31 | $0 | 3 | 0.33 |
| 2023-06-30 | $5.9k | 5.9k | 1.00 |
| 2022-12-31 | $2.3k | 5.0k | 0.46 |
| 2022-09-30 | $7.0k | 6.8k | 1.03 |